A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis

N Engl J Med. 2021 Mar 25;384(12):1113-1124. doi: 10.1056/NEJMoa2028395.Epub 2020 Nov 13.

Philip N Newsome, Kristine Buchholtz, Kenneth Cusi, Martin Linder, Takeshi Okanoue, Vlad Ratziu, Arun J Sanyal, Anne-Sophie Sejling, Stephen A Harrison, NN9931-4296 Investigators

PMID: 33185364 DOI: 10.1056/NEJMoa2028395

https://pubmed.ncbi.nlm.nih.gov/33185364